|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.9 NOK | +1.70% |
|
0.00% | +2.58% |
| Apr. 24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
Vistin Pharma ASA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was NOK 438.33 million compared to NOK 304.85 million a year ago. Net income was NOK 45.64 million compared to net loss of NOK 4.69 million a year ago.
Basic earnings per share from continuing operations was NOK 1.03 compared to basic loss per share from continuing operations of NOK 0.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.58% | 95.97M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
VISTIN PHARMA ASA 
